![]() |
市场调查报告书
商品编码
1324320
到 2030 年医用工程材料的市场预测 - 按类型、用途和地区分類的全球分析Medical Engineered Materials Market Forecasts to 2030 - Global Analysis By Type (Medical Adhesives, Medical Foams, Medical Plastics, Medical Elastomer, Medical Films and Other Types), Application and By Geography |
根据Stratistics MRC预测,2023年全球医疗工程材料市场规模将达到230.2亿美元,预计在预测期内将以14.6%的年复合成长率成长,到2030年达到597.7亿美元。
医疗产品和服务(例如消耗品、设备和其他物品)是在称为医疗工程材料 (MEM) 的材料的帮助下製造的。这些零件设计用于医疗设备製造、施工和安全。这些是高价值材料,其性能始终优于标准材料,从而带来更轻的产品、更宽的温度范围、多种用途或在整个使用寿命内改进的性能。
总部位于瑞士的政府机构世界卫生组织 (WHO) 表示,到 2020 年,慢性病的盛行率预计将上升 57%。
奈米工程组件可用于创建心室的微型模型并治疗与心臟相关的疾病。医疗设备中对工程材料的需求是由人口变化所驱动的,包括人口高龄化和新的疾病菌株。在全球范围内,人口高龄化正在对产品设计和生产产生重大影响。在医疗保健领域,世界各地正在投入大量资金来升级设施和开发最先进的设备。因此,慢性疾病患者数量的增加正在刺激市场的扩大。
医疗废弃物属于含有传染性成分的废弃物类别。它由兽医诊所、医院、实验室和医学研究设施等医疗机构产生的排放结构。医疗产业产生的废弃物中很大一部分是塑胶。一些一次性器械经过再处理后可以再次使用。然而,这些产品被丢弃是因为它们没有充分净化,有人担心它们可能会引起感染疾病。儘管生产商开始收集塑料,但市场面临塑料废弃物的重大挑战。
医疗设备和仪器的製造严重依赖人造材料。专为医疗用途设计的材料是专门为满足特定设备的要求而製造的。可修改以满足规格以提供包括生物可降解性、渗透性和抗菌特性等品质的产品的需求正在为市场的快速增长创造机会。在过去的十年中,合成材料在医疗行业的使用显着增加。这些工程材料用于取代金属、陶瓷和玻璃等传统材料。
政府法规医疗保健设施的成本,以确保全民享有医疗保健设施。因此,医疗器材製造商和原料供应商将不得不控製成本。随着成本的降低,这些公司的利润率也随之下降。全球医疗保健领域受到严格法规。医疗器材审批机构使用各种方法来评估产品性能和安全性,并在不同的时间内授予产品认证。市场抑制因素包括政府对医疗器材成本的控制、各种法规以及冗长的审批程序。
由于 COVID-19,对个人防护装备 (PPE) 套件、口罩、窗帘和手套的需求增加。容量限制迫使医疗机构扩大基础设施并使其现代化,以适应不断增长的患者数量。不仅民众对个人防护装备和口罩的需求不断增加,医疗保健产业的各个领域也对个人防护装备和口罩的需求不断增加。在大流行期间,患者照护系统、热扫描仪和相关设备的成长速度都可能比其他医疗设备更快。呼吸器是对抗新冠病毒的重要武器,需要塑胶、黏剂和弹性体等原料的快速供应、充足且及时的物流支援以及法规的批准。
预计医用塑胶领域将出现良好成长。医用塑胶是用于製造一次性医疗用品和医疗设备的最常见的其他医疗工程材料。医疗一次性用品、仪器、用具和药物输送系统均由塑胶製成。开发中国家慢性病市场的开拓和医疗基础设施的扩大预计将导致医疗器材市场的振兴,从而刺激对医用塑胶的需求。
预计医疗一次性用品领域在预测期内将出现最快的年复合成长率。用于生产一次性医疗用品和医疗器材的最常见的其他医疗工程材料是医用塑胶。医疗一次性用品、仪器、用具和药物输送系统均由塑胶製成。开发中国家慢性病市场的开拓和医疗基础设施的扩大预计将重振医疗器材市场,并有望提振市场需求。
由于快速扩张,预计亚太地区在预测期内将占据最大的市场份额。生产药品的製药公司和医疗器材製造商被吸引到该地区。当前系统中基于价值的护理的变化、价值链上的生态系统合作伙伴关係、增加的研发以及医疗保健系统的数位化是医疗器材业务的关键促进因素。
预计欧洲在预测期内的年复合成长率最高。对更好的医疗设施的需求以及与生活方式相关的疾病的增加正在推动欧洲市场的发展。此外,该领域市场的快速扩张归因于3D列印和数位化等新技术在医疗器材製造中的越来越多的使用。
According to Stratistics MRC, the Global Medical Engineered Materials Market is accounted for $23.02 billion in 2023 and is expected to reach $59.77 billion by 2030 growing at a CAGR of 14.6% during the forecast period. Medical products and services such as disposables, equipment, and other items are made with the help of materials known as medical engineered materials (MEM). These components are designed to be used in the manufacture, construction, and safety of medical equipment. These are high-value materials that always perform better than standard materials, resulting in lighter goods, greater service temperature ranges, multipurpose use, or improved performance over the course of their whole life.
According to the World Health Organization, a Switzerland-based government agency, chronic disease prevalence is expected to rise by 57% by the year 2020.
The nano engineered components can be utilized to create a tiny model of a heart chamber and treat heart-related conditions. The demand for engineered materials in medical devices is driven by shifting demographics, including the aging population and emerging disease strains. Globally, the aging population growth is significantly influencing product design and production. Significant expenditures are being made worldwide in the healthcare sector to upgrade the facilities and create cutting-edge equipment. Therefore, the rise in chronic disease cases is fueling the market's expansion.
Medical wastes fall under the category of waste with infectious elements. It comprises the trash produced by healthcare facilities such veterinary clinics, hospitals, labs, and facilities for doing medical research. A sizable portion of the trash produced in the medical industry is plastic. After reprocessing, several single-use gadgets can also be used again. However, these products are disposed of because of concern that they won't be sufficiently decontaminated and cause an infection. Although producers have begun recovering plastic, the market still faces significant challenges from plastic waste.
The production of medical equipment and devices heavily relies on engineered materials. Medically designed materials are created specifically to meet the requirements of a given equipment. Opportunities for the market to grow rapidly are being created by the demand for products that can be modified to meet specifications for providing qualities including biodegradability, radio-opacity, and antibacterial characteristics. In the past ten years, the medical industry has used synthetic materials far more frequently. In place of conventional materials like metals, ceramics, and glass are these designed materials.
Governments regulate healthcare facility costs to guarantee universal access to the facilities. As a result, producers of medical devices and suppliers of raw materials must keep costs under control. Along with cost reduction, this lowers these players' profit margins. The world's healthcare sector is heavily regulated. Medical device approval agencies use a variety of techniques to evaluate the performance and safety of their products and grant product clearance throughout a range of time frames. Some market restraints include government control over medical device costs, a variety of regulations, and drawn-out approval procedures.
Personal protective equipment (PPE) kits, masks, drapes, and gloves are in higher demand as a result of the COVID-19. Healthcare facilities have been forced to expand and modernize their infrastructure due to capacity limitations in order to accommodate the growing patient intake. All areas of the medical sector as well as the general public have a strong demand for PPE kits and masks. Patient care systems, thermal scanners, and related equipment will all increase more quickly than other medical devices during the pandemic. Ventilators are essential weapons in the fight against the corona virus, which necessitates a quicker supply of raw materials like plastics, adhesives, and elastomers as well as appropriate and prompt logistical support and regulatory approvals.
The medical plastics segment is estimated to have a lucrative growth. The most common type of other medically designed materials used in the production of disposable medical items and devices is medical plastics. Medical disposables, instruments, and tools, as well as medication delivery systems, can all be made of plastics. Growing chronic disease rates and expanding healthcare infrastructure in developing nations are anticipated to fuel the market for medical devices, which will likely fuel demand for medical plastics.
The medical disposables segment is anticipated to witness the fastest CAGR growth during the forecast period. The most common type of other medically designed materials used in the production of disposable medical items and devices is medical plastics. Medical disposables, instruments, and tools, as well as medication delivery systems, can all be made of plastics. Growing chronic disease rates and expanding healthcare infrastructure in developing nations are anticipated to fuel the market for medical devices, which will likely fuel demand for the market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the rapid expansion. Pharmaceutical enterprises that make drugs and manufacturers of medical equipment have found the area to be appealing. The value-based care changes in current systems, ecosystem partnerships along the value chain, increased R&D, and digitalization of the healthcare system are the primary drivers for the medical devices business.
Europe is projected to have the highest CAGR over the forecast period. The desire for better healthcare facilities and the increase in disorders linked to lifestyle are what are driving the European market. Additionally, the rapid expansion of the market in this sector is due to the rising use of new technologies like 3D printing and digitization in the manufacturing of medical equipment.
Some of the key players profiled in the Medical Engineered Materials Market include: Evonik, SABIC, BASF, 3M Company, Eastman Chemical Company, Huntsman Corporation, Koninklijke DSM N.V., Celanese Corporation, Teknor Apex Company, Ethicon Inc., DuPont, Solvay, DSM, Nitto Denko, Sekisui Chemical, Trelleborg AB and Covestro AG.
In February 2023, Covestro launches new ultra-durable material solution for healthcare and life sciences. Covestro, a leading producer of advanced polymers and high-performance plastics in the United States and around the world, developed Makrolon® 3638 polycarbonate.
In October 2022, Covestro has developed a proof-of-concept heat-resistant coating for use on mono-PE stand-up pouches made with SABIC® BOPE polymer. The coating facilitates the industrial-scale production of BOPE-based mono-material stand-up pouches on horizontal form-fill-seal (HFFS) lines.